Skip to main content
. 2020 Sep 12;28(11):1374–1382. doi: 10.1016/j.jsps.2020.09.001

Table 3.

Properties of venlafaxine HCl FDOF formulations.

Formulation Drug content (mg) ± SD Thickness (mm) Folding endurance pH ± SD Moisture content
F1 23.95 ± 1.63 0.31 1 4.26 ± 0.04 4.64
F2 23.65 ± 0.83 0.28 4 2.9 0 ± 0.02 0.66
F3 24.32 ± 1.38 0.35 1 4.20 ± 0.11 2.42
F4 21.76 ± 0.99 0.24 1 3.79 ± 0.04 3.01
F5 24.23 ± 1.60 0.30 12 3.9 0 ± 0.05 5.69
F6 23.24 ± 0.59 0.26 3 3.79 ± 0.01 2.85
F7 23.71 ± 0.56 0.30 3 2.99 ± 0.01 2.79
F8 23.74 ± 0.16 0.30 4 4.23 ± 0.00 3.67
F9 22.11 ± 0.50 0.26 2 3.85 ± 0.02 2.33
F10 22.85 ± 0.27 0.28 3 2.92 ± 0.01 2.40
F11 23.24 ± 0.68 0.32 2 4.17 ± 0.01 2.34
F12 23.18 ± 0.44 0.25 2 4.17 ± 0.01 2.51
F13 21.76 ± 0.99 0.27 1 3.79 ± 0.01 2.16
F14 23.71 ± 1.69 0.24 1 2.98 ± 0.00 0.69
F15 23.66 ± 1.13 0.24 1 3.83 ± 0.01 1.84
F16 22.84 ± 0.59 0.27 1 3.76 ± 0.01 1.22
F17 23.08 ± 0.38 0.30 7 3.88 ± 0.01 2.04
F18 23.09 ± 0.64 0.35 5 4.23 ± 0.02 4.62
F19 22.66 ± 1.54 0.28 1 3.81 ± 0.02 2.89
F20 23.94 ± 0.24 0.26 3 3.06 ± 0.01 1.86
F21 22.94 ± 1.59 0.26 3 4.28 ± 0.01 3.98
F22 24.67 ± 0.30 0.26 3 2.93 ± 0.01 1.89
F23 23.47 ± 0.76 0.26 1 2.9 ± 0.03 3.40
F24 22.26 ± 0.61 0.20 1 2.96 ± 0.02 2.46
F25 23.41 ± 2.41 0.24 1 4.16 ± 0.02 1.46
F26 23.72 ± 1.23 0.25 1 4.19 ± 0.03 1.05
F27 24.84 ± 0.43 0.23 4 2.96 ± 0.02 1.99